摘要
1病例资料 患者,女性,71岁,因＂发作性胸骨后疼痛16h＂入院。既往有高血压病史30年,自服药物治疗。糖尿病史3年,皮下注射胰岛素治疗。13年前因肾功能衰竭行肾移植术,术后一直服用免疫抑制剂。入院体检：体温36.6℃,脉搏16次/min,呼吸18次/min,血压130/85 mmHg（1 mmHg=0.133kPa）。营养中等,神志清楚,双肺未闻及干湿性啰音。
Renal transplantation is an effective treatment for end-stage renal disease.However,long-term use of immunosuppressive agents and glucocorticoids after transplantation will increase the incidence of cardiovascular disease,such as coronary artery disease（CAD）.Renal transplantation patients with chronic renal insufficiency are more likely to have hypertension,diabetes and other risk factors of CAD,and CAD is still one of the main causes of death of such patients.Percutaneous coronary intervention（PCI）is commonly used in patients with CAD after renal transplantation.The use of contrast agents in PCI,coupled with the presence of underlying kidney disease,increase the risk of incidence of contrast induced nephropathy.We report a case to explore the risk of contrast induced nephropathy after PCI and the prevention measures.
出处
《临床心血管病杂志》
CAS
CSCD
北大核心
2016年第6期648-649,共2页
Journal of Clinical Cardiology
关键词
冠心病
介入治疗
肾移植
coronary disease
intervention
renal transplantation
作者简介
通信作者：赵良平：E-mail：zhaoliangping1234@aliyun．com
